临床荟萃

• 专题 • 上一篇    下一篇

综合征的诊断和治疗

  

  1. 河北医科大学第二医院儿科,内分泌遗传代谢专业,河北 石家庄  050000
  • 出版日期:2019-10-20 发布日期:2019-12-09
  • 通讯作者: 张会丰, Email:13333015983@163.com
  • 作者简介:张会丰,河北医科大学二级教授、博士研究生导师。河北医科大学第二医院儿科主任,营养生长发育及内分泌专业主任。河北省儿童糖尿病诊断治疗中心主任,河北省有突出贡献的中青年专家,河北省医学会儿科分会候任主任委员,河北省医学会变态反应学分会主委。

Diagnosis and treatment of Noonan syndrome

  1. Department of Paediatrics, Endocrine and Genetic Metabolism,  the Second Hospital  of Hebei Medical University,  Shijiazhuang 050000,  China
  • Online:2019-10-20 Published:2019-12-09
  • Contact: Corresponding author: Zhang Huifeng, Email:13333015983@163.com

摘要: Noonan综合征是一种相对常见的常染色体显性遗传病,Noonan综合征遗传异质性很大,涉及多个学科,主要临床特征包括身材矮小、颅颌面畸形、先天性心脏缺陷、认知障碍等,还可以伴发一系列血液系统疾病,患肿瘤风险较普通人群增高。重组人生长激素治疗可协助改善Noonan综合征患者身高,同时需多学科协作,治疗其他系统存在的先天异常。本文总结Noonan综合征的临床特点和相关基因突变,以期为临床提供参考。

关键词: 短肋多指(趾)畸形综合征, 面容, 心脏缺损,  , 先天性, 生长激素

Abstract: Noonan syndrome is a relatively common autosomal dominant genetic disease. Genetic heterogeneity of Noonan syndrome has a large rang and involves multiple disciplines. Its main clinical features includes   short stature, craniomaxillofacial deformity,  congenital heart defects,  and cognitive impairment. It can also be accompanied by a series of diseases of the blood system,  and patients with Noonan syndrome have a higher risk of cancer compared to the general population. Recombinant human growth hormone therapy can help improve the height of patients with Noonan syndrome and requires multidisciplinary treatment of congenital abnormalities in other systems.The clinical characteristics and related gene mutations of Noonan syndrome were summarized so as to provide a reference for clinic research.

Key words: short ribpolydatyly syndrome, faces, heart defects, , congenital, growth hormone